Disinfection Cap Market Growth & Trends

The global disinfection cap market size is expected to reach USD 397.9 million by 2027, expanding at a CAGR of 3.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of hospital acquired diseases and rising hospital admissions are the key driving factors for the market. Hospital-acquired Infections (HAIs), also known as nosocomial infections, are primarily found in patients receiving long-term treatment, especially surgical treatment. It can occur in hospitals, surgical centers, clinics, ambulatory surgical centers, and long-term care facilities such as rehabilitation facilities and nursing homes. 

Generally, children, geriatric populations, and patients with low immunity are prone to HAIs. Factors such as use of indwelling catheters, lack of proper hygiene in the healthcare setting, and excessive use of antibiotics can increase the risk of HAIs in patients. Increasing cases of HAIs due to lack of sanitation and precaution is a key factor anticipated to propel the growth of the market for disinfection caps over the forecast period. According to a CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals.

As per a report published by European Centre for Disease Prevention and Control (ECDC) in 2018, prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year. Such cases are expected to increase the demand for disinfection caps. It is used to disinfect IV connectors and eliminate bacteria and other microorganisms. Such solutions are required in hospitals to maintain proper hygiene and sanitation, thereby lowering the risk of HAIs, which is anticipated to propel market growth over the forecast period.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/disinfection-cap-market

Disinfection Cap Market Report Highlights

• In terms of revenue, the non-retail segment held the largest market share in 2019. Hospitals and clinics, generally, have tie-ups with the manufacturers for purchasing the products
• The hospital segment held the largest market share in 2019 and is expected to witness the fastest growth over the forecast period due to the increasing incidences of hospital acquired infections
• In Asia Pacific, the disinfection cap market is expected to witness the fastest growth over the forecast period owing to the rising prevalence of cardiovascular, neurology, and urology disorders
• Prominent key players present in market are BD, 3M, ICU Medical, Merit Medical, and B. Braun Melsungen AG.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/disinfection-cap-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Sterile Tubing Welder Market Worth $3.19 Billion By 2027

The global sterile tubing welder market size is expected to reach USD 3.19 billion by 2027, expanding at a CAGR of 4.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for blood, blood products, and biopharmaceutical products is anticipated to drive the market for sterile tubing welder.

Blood transfusion is one of the frequently performed medical procedures. Severe road traffic injuries, major surgical procedures, and hematology diseases, such as thalassemia, anemia, and leukemia, are some of the key reasons for the transfusion procedure. According to the Association for Safe International Road Travel (ASIRT) article, nearly 20 to 50 million individuals are injured or disabled in road accidents. Thus, high cases of road traffic injuries are anticipated to fuel sterile tubing welder market growth.

Wastage of collected blood due to contamination, blood bag leakages, improper storage, and lack of proper handling facilities and qualified professionals are anticipated to increase the demand for innovative and medically advanced sterile instruments, such as automated sterile tubing welders. For instance, in India, nearly 10% of blood components and around 71% of whole blood are wasted each year due to the above-stated reasons.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/sterile-tubing-welders-market

Further key findings from the study suggest:

• Based on mode, the automatic sterile tubing welders dominated the market in 2019 and is anticipated to witness the highest growth over the forecast period due to ease of operation and reduced labor costs
• On the basis of application, the blood processing segment held a substantial share in 2019 due to a large number of patients being treated using apheresis annually across the globe
• By end use, hospitals held a significant share in 2019 owing to rise in the adoption of advanced instruments and enhanced services in these settings
• North America dominated the market for sterile tubing welder in 2019. This can be attributed to the presence of numerous biopharmaceutical companies and high demand for biopharmaceutical products
• Asia Pacific is anticipated to witness lucrative growth over the forecast period due to a large number of clinical trials being conducted and rise in the number of medical device companies in the region
• Some of the key companies operating in the sterile tubing welder market are Sartorius Stedim Biotech S.A., Terumo BCT Inc, GE Healthcare, MGA technologies, VANTE Biopharm, Genesis BPS, Biomen Biosystems Company Ltd, Flex Concepts Inc, and Shanghai Le Pure Biological Technology Co., Ltd.
• Mergers & acquisitions are the key strategies adopted by the market players.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/sterile-tubing-welders-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Patient Registry Software Market Size Worth $2.3 Billion By 2027

The global patient registry software market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increasing demand for integrated healthcare systems is fueling the demand for patient registry software. Surmounting burden to curb the healthcare cost is expected to fuel market growth via higher penetration and untapped opportunities. Lack of patient information access was found to be a major barrier for integrating care and proper treatment option in both developed and developing countries, which is further driving the market.

Increasing number of clinical trials by major pharmaceutical and biotechnological companies is expected to drive the patient registry software market over the forecast period. The data obtained via patient registry software helps in tracking patients for clinical trials. Moreover, associated advantages such as increased cost-effectiveness, efficient resource management, and reduced healthcare IT cost, are further widening the scope for market growth. The industry players are also constantly trying to develop advanced registries which can be easily integrated with national registries for a better outcome.

For instance, in September 2019, Elekta signed a distribution agreement with DocSoft for the key patient-specific QA solution software namely EPIgray, MU2Net, and EPIbeam. These software will help to analyze the treatment plan for any diagnosed condition, for future purposes. This agreement is expected to increase the company’s market penetration in the coming years.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/patient-registry-software-market

Further key findings from the report suggest:

• Disease registry held the largest revenue share in the patient registry software market owing to the increasing demand to curb the disease burden and stringent regulations by the government bodies
• The standalone segment held the largest share in 2019 and is expected to witness a CAGR of over 11.0% by 2027. The growth can be attributed to advanced features offered by the software such as easy data retrieval and auto upgradation
• The on-premise segment held the largest revenue share in 2019. This is due to enhanced data security options and ease of access
• The public database type segment is expected to show the fastest growth over the forecast period owing to its increased usage for research purposes
• The population health management segment held the largest revenue share in 2019. This is due to its growing adoption in developed countries for better patient care
• The pharma and medical device companies segment is expected to show the fastest growth over the forecast period, owing to the increasing use of registries by these companies for clinical trial enrollment
• Asia Pacific is expected to emerge as the fastest-growing region in this space. Moreover, North America held the largest revenue share due to its established healthcare structure and stringent regulations by the government bodies
• Some of the major players include IBM; IQVIA; Elekta AB; McKesson Corporation; Dacima Software Inc.; Phytel, Inc.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/patient-registry-software-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Pediatric Imaging Market Worth $12.2 Billion By 2027

The global pediatric imaging market size is expected to reach USD 12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of pediatric trauma cases are expected to accelerate the demand for innovative patient screening, which is expected to augment the market growth.

According to the Centers for Disease Control and Prevention (CDC), an estimated 812,000 children aged 17 or below were treated in the U.S. Emergency Department (ED) for concussion or Traumatic Brain Injury (TBI) in 2014. CDC further stated that injuries due to falling accounted for an approximate 49% of all TBI-related ED visits in children. In addition, increasing focus of market players on product development and innovation is expected to drive the market growth. For instance, in June 2019, Carestream Health, Inc. launched a portable Carestream DRX Plus 2530C X-ray detector with cesium iodide technology, which captures minute details of anatomical structures in pediatric patients.

North America accounted for the largest share in 2019 owing to favorable reimbursement policies, faster adoption of innovative imaging modalities, and growing consumer preference toward noninvasive diagnosis. Increasing investments in order to propel technological innovation is expected to augment the pediatric imaging market growth in the region. For instance, in 2018, Bracco Diagnostics Inc. provided a grant of USD 300,000 to Children’s Hospital of Philadelphia (CHOP), to fund research and train technicians to use a new technology of contrast ultrasound. Also, medical coverage is granted by the Children's Health Insurance Program (CHIP) for pediatric patients in U.S., which covers imaging services, is a major factor propelling the market growth.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/pediatric-imaging-market

Further key findings from the report suggest:

• The magnetic resonance imaging modality segment dominated the market owing to high usage in hospital settings and higher recommendations by radiologists due to safety
• By application, the orthopedic/ trauma segment is expected to register the highest CAGR due to rising incidence of bone defects in children combined with increasing cases of ED visits related to trauma
• By end user, the hospital segment accounted for the largest market share owing to large number of installed systems in hospital settings and direct collaborations of hospitals with market vendors, thereby offering access to novel and advanced imaging systems
• Leading players present in the pediatric imaging market include GE Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V. (Royal Philips); Fujifilm Holdings Corporation; Toshiba Medical Systems Corporation; Samsung Electronics Co., Ltd.; Agfa Healthcare; and Carestream Health, Inc.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/pediatric-imaging-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Veterinary Oncology Market Size Worth $447.0 Million By 2027

The global veterinary oncology market size is expected to reach USD 447.0 million by 2027, expanding at a CAGR of 10.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/veterinary-oncology-market

Further key findings from the report suggest:

• Increasing prevalence of cancer in animals, clinical trial studies to evaluate safety and effectiveness of cancer therapeutics, and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market
• The chemotherapy segment is anticipated to account for the largest revenue share over the coming years owing to its increasing adoption either alone or in combination with other therapies
• The canine segment held the largest revenue in 2019 owing to increasing population of dogs and high prevalence of cancer in dogs as compared to cats
• Lymphoma dominated the market among other cancer types in 2019, due to high mortality rate in companion animals
• North America held the dominant share of the veterinary oncology market in 2019, due to favorable government policies, new product launches, and huge investment in oncology treatment
• Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pets being exposed to cancer, and government focus on animal safety and initiatives to curb cancer in pet animals
• Some of the key companies are Boehringer Ingelheim; PetCure Oncology; Elanco; Accuray Incorporated; Varian Medical Systems; Zoetis; Karyopharm Therapeutics, Inc.; One Health; and Regeneus Ltd.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/veterinary-oncology-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Hereditary Testing Market: Latest advancement & Technology

The global hereditary testing market size is expected to reach USD 8.9 billion by 2026, expanding at a CAGR of 6.3% over the forecast period, according to a new report by Grand View Research, Inc. Key factors driving the market are declining cost of sequencing and availability of genetic tests at a lower price. Furthermore, the availability of niche and fragmented point-solutions across genomics value chain, namely sequencing, analytics, interpretation, aggregation, and marketplace, is anticipated to propel the market growth over the forecast period.

The advent of direct-to-consumer genetics is anticipated to play a major role in the genetic testing market by enabling individuals to carry out self-testing. This expands the role of genetic counselors, which further aids in understanding the importance of genetic tests and helps in the selection of appropriate tests. A growing number of registered genetic counselors is anticipated to boost the adoption of hereditary genetic tests in the coming years.

Technology developers are introducing advanced products to enhance the efficiency of genetic tests by diagnostic companies. For example, in June 2019, QIAGEN launched a new QIAseq Expanded Carrier Screening Panel, a novel Next-generation Sequencing (NGS) panel integrated with advanced bioinformatics solutions for rare and inherited diseases testing. Such ongoing developments in the market space are expected to boost revenue growth to a large extent in the coming years.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/hereditary-testing-market

Hereditary Testing Market Report Highlights

• A substantial number of CLIA-certified laboratories perform tests to determine whether an individual carries an inherited mutated gene that can cause cancer. This has led to increased hereditary testing market share of hereditary testing for cancer in 2019
• Breast cancer testing segment has dominated the hereditary cancer testing market owing to its high penetration and increased inheritability
• On the other hand, most of the cases of cervical cancer are non-hereditary, resulting in the lowest revenue share of this segment
• Emergence of high-throughput sequencing has resulted in commercial availability of a significant number of sequencing assays for cardiomyopathies, thereby driving the cardiac diseases segment
• Non-invasive Prenatal Testing (NIPT) and newborn genetic screening continue to witness lucrative growth due to increased adoption across the globe
• Moreover, the newborn screening program has been made mandatory in several regions and countries, resulting in large share of these test types among the hereditary non-cancer testing segment
• Europe and North America collectively accounted for nearly 70% of the revenue generated in 2019 owing to assisted reproductive technology space coupled with high penetration of newborn genetic screening
• Myriad Genetics, Inc.; Quest Diagnostics Incorporated; Invitae Corporation; Illumina, Inc.; and Natera, Inc. are some of the major key players operating in the marketplace
• These companies are engaged in securing regulatory approval in the emerging countries to expand their business footprint
• A substantial number of diagnostic companies have collaborated with technology developers to obtain technology license and deliver high value services to their customers.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/hereditary-testing-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Continuous Passive Motion Devices Market Worth $1.1 Billion By 2026

The global continuous passive motion devices market size is expected to reach USD 1.1 billion by 2026, according to a new report by Grand View Research, Inc. The increasing number of government initiatives along with the increasing number of ageing population are expected to drive the market growth over the forecast period.

CPM is initiated in the recovery room immediately post surgery procedure or during the early postoperative period. The therapy time may range from 1 to 24 hours of treatment per day and is used as an adjunct to physical therapy that may continue for 1 to 6 weeks depending on the degree of rehabilitation required. In February 2016, BTL launched BTL-CP Motion with 13 automatic preset protocols and 50 user defined protocols that improves movement for better therapy outcomes.

Factors such as the rising prevalence of disorders linked with trauma, joint replacement, or ligament reconstruction boost the CPM devices market. Osteoporosis decreases bone density, causing fracture even after a minor trauma incidence. The condition affects around 8.9 million population annually. The growing concern associated with population suffering from poor bone health has resulted in the development of efficient outpatient rehabilitation systems. Moreover, the improvement in reimbursement scenario, and the preference for minimal invasion offered by CPM devices as compared to surgical procedures are expected to boost the market growth.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/continuous-passive-motion-devices-market

Further Key Findings From the Report Suggest:

• Knee joints dominated the type segment in 2018, whereas hip joint is anticipated to witness significant growth over the forecast period.
• The growth of knee joints CPM devices is attributed to factors such as the increasing number of knee arthroplasty. The rise in road traffic accidents increases the number of orthopedic surgeries performed worldwide. Improvement of care in such cases involves ensuring better quality of post-hospital care, such as through CPM training program.
• Based on design, the market is segmented into fixed and portable devices wherein fixed devices dominated the market while portable CPM devices is anticipated to grow at the fastest rate owing to the increasing use of devices in home setting.
• On the basis of demographics, the market is segmented into adults (18 and above) and children (below 18) wherein adult population dominated the segment market owing to increasing number of ageing population with joint disorder.
• North America dominated the continuous passive motion devices market in 2018 in terms of revenue share owing to the rising government initiative to increase patient access to outpatient rehabilitation.
• Key industry participants of this market include Furniss Corporation; Surgi-Care, Inc.; Bio-Med Inc.; BTL Corporate; Chattanooga; and Chinesport Rehabilitation

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/continuous-passive-motion-devices-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Ophthalmic Sutures Market Worth $532.8 Million By 2026

The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market are rising geriatric population prone to eye-related disorders, coupled with increasing awareness regarding advanced surgical procedures. Increasing aging population is expected to contribute to the rising burden of glaucoma around the world. According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.

Visual impairment is a global health concern. According WHO, it is estimated that around 1.3 million people live with some form of vision impairment currently. Technological advancements in the field of ophthalmology, such as self-sealing incisions, are expected to fuel market growth. Other factors driving the market are increasing awareness about various eye diseases, coupled with increasing number of ophthalmologists and better reimbursement policies.

Various government initiatives, increasing investments in research and development, and rising healthcare spending are also expected to propel the market over the forecast period. Furthermore, increasing number of ambulatory surgical centers and single-day surgeries is expected to propel the market. Most of the ophthalmic procedures are single-day surgeries, which do not require hospital stay. Thus, with increasing number of outpatient surgeries, the ophthalmic sutures market is expected to witness lucrative growth over the forecast period.

Full Research Report On Ophthalmic Sutures Market Visit Here: https://www.grandviewresearch.com/industry-analysis/ophthalmic-sutures-market

Ophthalmic Sutures Market Report Highlights

• Based on type, the synthetic sutures segment dominated the market in 2018, which can be primarily attributed to low rate of inflammatory reactions around wound site and higher durability
• By way of absorption capacity, non-absorbable sutures led the market owing to benefits such as reduced chances of postoperative surgical infection and its ability to be removed after few days of surgery
• On the basis of application, the cataract surgery segment was valued at USD 130.8 million in 2018 owing to high prevalence rate and large number of surgical procedures
• Based on end use, ambulatory surgical centers held the largest share of more than 40.0% in 2018, fueled by large number of single-day procedures, which do not require hospital stay
• North America held the dominant share owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
• Key players in the market include Accutome, Inc.; Assut Medical Sarl; Alcon Inc.; Aurolab; B Braun Melsungen AG; DemeTech Corporation; FCI Ophthalmic Inc.; Medtronic Plc; Rumex International Co.; Surgical Specialties Corp; Teleflex Incorporated; and Unilene.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/ophthalmic-sutures-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com